EN
CN EN
SUYA-HR
Human Rabies Immunoglobulin
Name
Human Rabies Immunoglobulin
Use within
24 months
Specifications
100IU/vial (100IU/ml, 1ml)
200IU/vial (100IU/ml, 2ml)
500IU/vial (100IU/ml, 5ml)
Approval number
100IU/vial (100IU/ml, 1ml) - NMPA Approval No. S20053014
200IU/vial (100IU/ml, 2ml) - NMPA Approval No. S20053015
500IU/vial (100IU/ml, 5ml) - NMPA Approval No. S20053016
Indications
Used for the passive immunization of patients bitten or scratched by rabid or other mad animals.All patients suspected of exposure to rabies should be treated with both rabies vaccine and rabies immunoglobulin.If the patient has been vaccinated against rabies and has sufficient levels of rabies antibodies, only vaccination is required, without the use of this product.